Drug-delivery and multifunction possibilities of hypocrellin photosensitizers

Hong Deng; Jie Xie; Jingquan Zhao

doi:10.1142/s1793545815300037

[1] C. Hopper, "Photodynamic therapy: A clinical reality in the treatment of cancer," Lancet Oncol. 1, 212–229 (2000).

[2] H. X. Qiu, Y. Gu, Y. Wang, N. Y. Huang, "Twenty years of clinical experience with a new modality of vascular-targeted photodynamic therapy for port wine stains," Dermatol. Surg. 37, 1603–1610 (2011).

[3] H. R. Coleman, C. C. Chan, F. L. Ferris, E. Y. Chew, "Age-related macular degeneration," Lancet 372, 1835–1845 (2008).

[4] M. Ishizuka, F. Abe, Y. Sano, K. Takahashi, K. Inoue, M. Nakajima, T. Kohda, N. Komatsu, S. Ogura, T. Tanaka, "Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy," Int. Immunopharma. 11, 358–365 (2011).

[5] B. Khoobehi, R. Grinstead, E.Passos, "Experimental photodynamic effects of hypocrellin A on the choriocapillaris," Ophthalmic. Surg. Las. 33, 207–213 (2002).

[6] L. J. Jiang, Y. Y. He, "Photophysics, photochemistry and photobiology of hypocrellin photosensitizers," Chin. Sci. Bull. 46, 6–16 (2001).

[7] G. G. Miller, K. Brown, A. M. Ballangrud, O. Barajas, Z. Xiao, J. Tulip, J. W. Lown, J. M. Leitho , M. J. Allalunis-Turner, R. D. Mehta, R. B. Moore, "Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: Progress update," Photochem. Photobiol. 65, 714–722 (1997).

[8] P. F. Santos, L. V. Reis, P. Almeida, J. P. Serrano, A. S. Oliveira, L. F. V. Ferreira, "E±ciency of singlet oxygen generation of aminosquarylium cyanines," J. Photochem. Photobiol. A-Chem. 163, 267–269 (2004).

[9] V. Engelhardt, T. Kiesslich, J. Berlanda, S. Hofbauer, B. Krammer, K. Plaetzer, "Lipophilic rather than hydrophilic photosensitizers show strong adherence to standard cell culture microplates under cell-free conditions," J. Photochem. Photobiol. BBiol. 103, 222–229 (2011).

[10] M. Ishikawa, Y. Hashimoto, "Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry," J. Med. Chem. 54, 1539–1554 (2011).

[11] S. H. Hautmann, V. B. Lokeshwar, G. L. Schroeder, F. Civantos, R. C. Duncan, R. Gnann, M. G. Friedrich, M. S. Soloway, "Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer," J. Urol. 165, 2068–2074 (2001).

[12] C. Bing, S. T. Russell, E. E. Beckett, P. Collins, S. Taylor, R. Barraclough, M. J. Tisdale, G. Williams, "Expression of uncoupling proteins-1,-2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor," Brit. J. Cancer 86, 612–618 (2002).

[13] S. J. Xu, S. Chen, M. H. Zhang, T. Shen, "First synthesis of methylated hypocrellin and its fluorescent excited state: A cautionary tale," J. Org. Chem. 68, 2048–2050 (2003).

[14] K. Das, D. S. English, J. W. Petrich, "Solvent dependence on the intramolecular excited-state proton or hydrogen atom transfer in hypocrellin," J. Am. Chem. Soc. 119, 2763–2764 (1997).

[15] S. Ebrahim, G. A. Peyman, P. J. Lee, "Applications of liposomes in ophthalmology," Surv. Ophthalmol. 50, 167–182 (2005).

[16] C. L. Yu, S. Chen, M. H. Zhang, T. Shen, "Spectroscopic studies and photodynamic actions of hypocrellin B in liposomes," Photochem. Photobiol. 73, 482–488 (2001).

[17] Y. Zhang, J. Xie, L. Y. Zhang, C. Li, H. X. Chen, Y. Gu, J. Q. Zhao, "A novel elsinochrome A derivative: A study of drug delivery and photodynamic activity," Photochem. Photobiol. Sci. 8, 1676–1682 (2009).

[18] Z. J. Wang, Y. Y. He, C. G. Huang, J. S. Huang, Y. C. Huang, J. Y. An, Y. Gu, L. J. Jiang, "Pharmacokinetics, tissue distribution and photodynamic therapy e±cacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy," Photochem. Photobiol. 70, 773–780 (1999).

[19] J. Q. Zhao, X. Y. Jin, J. Xie, "Solid powder preparation from liposome of Hypocrellin and producing method," Patent CN1539407-A. Oct. 27-(2005).

[20] J. Xie, Y. Zhang, J. Zhao, "Hypocrellin liposome formulation, comprises hypocrellin, phospholipids, cholesterol and lyophilization protecting agent," Patent CN101371828-A. Feb. 25 (2009).

[21] H. X. Chen, Z. F. Yang, X. B. Zou, J. G. Zhu, H. Deng, J. Q. Zhao, Y. Gu, "Photodynamic e±cacy of liposome-delivered hypocrellin B in microvascular endothelial cells in vitro and chicken combs in vivo: A potential photosensitizer for port wine stain," Laser Phys. 23, 025605 (2013).

[22] Z. Zhang, W. Zhang, H. Zhang, "Bio-insecticide containing hypocrelline A," Patent CN96120599-A. Jun. 3 (1998).

[23] J. Zhao, H. An, J. Xie, "Pesticide useful in e.g. grain, cotton, fruit, vegetable and tobacco, comprising hypocrellin B and non-ionic surfactant such as octyl phenol polyethenoxy ether or octyl phenol polyethenoxy ether, except water," Patent CN1481680- A. Mar. 17 (2004).

[24] H. B. An, J. Xie, J. Q. Zhao, Z. S. Li, "Photogeneration of free radicals ((OH)-O-center dot and HB center dot-) and singlet oxygen (O-1(2)) by hypocrellin b in TX-100 micelles microsurroundings," Free Radical Res. 37, 1107–1112 (2003).

[25] J. Q. Zhao, X. Liu, Y. Gu, L. H. Liu, "Microemulsion of hypocrellin, and its preparing method," Patent CN101002757-A. Jul. 25 (2007).

[26] J. Zhao, B. Zhao, J. Xie, "Hypocrellin water-soluble nanogranule containing protein and polysaccharide useful for intravenous injection," Patent CN03148147-A. Jan. 19 (2005).

[27] B. Z. Zhao, J. Xie, J. Q. Zhao, "A novel water-soluble nanoparticles of hypocrellin B and their interaction with a model protein: C-phycocyanin," Biochim. Biophys. Acta 1670, 113–120 (2004).

[28] L. Zhou, J. H. Liu, S. H. Wei, Y. Y. Feng, J. H. Zhou, B. Y. Yu, "DNA combining and photocleaving properties of photosensitizer-encapsulated silica nanoparticles," Monatsh. Chem. 140, 1167–1170 (2009).

[29] L. Zhou, W. Wang, S. H. Wei, Y. Y. Feng, J. H. Zhou, J. H. Liu, J. Shen, "Encapsulation of hydrophobic anticancer drug in nano-scale porous ceramic materials for photodynamic therapy," J. Porous Mater. 18, 517–522 (2011).

[30] Z. B. Li, J. G. Wang, J. R. Chen, W. H. Lei, X. S. Wang, B. W. Zhang, "Hypocrellin B doped and pHresponsive silica nanoparticles for photodynamic therapy," Sci. Chin. Chem. 53, 1994–1999 (2010).

[31] G. Paramaguru, R. V. Solomon, P. Venuvanalingam, R. Renganathan, "Spectroscopic studies on TiO2 enhanced binding of hypocrellin B with DNA," J. Fluoresc. 21, 1887–1895 (2011).

[32] D. X. Li, C. F. Li, A. H. Wang, Q. He, J. B. Li, "Hierarchical gold/copolymer nanostructures as hydrophobic nanotanks for drug encapsulation," J. Mater. Chem. 20, 7782–7787 (2010).

[33] L. Gao, J. B. Fei, J. Zhao, H. Li, Y. Cui, J. B. Li, "Hypocrellin-loaded gold nanocages with high two- Photon e±ciency for photothermal/photodynamic cancer therapy in vitro," Acs Nano 6, 8030–8040 (2012).

[34] J. Q. Zhao, H. Deng, J. Xie, X. Liu, Y. Zhang, N. Y. Huang, Y. Gu, "Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases," Mini-Rev. Med. Chem. 10, 332–341 (2010).

[35] H. Deng, X. Liu, J. Xie, R. Yin, N. Y. Huang, Y. Gu, J. Q. Zhao, "Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity," J. Med. Chem. 55, 1910–1919 (2012).

[36] H. L. Liu, F. G. Liu, Y. Gu, J. H. Ma, J. Q. Zhao, J. Zeng, X. S. Li, "An experimental study of photodynamic effect of hypocrelline B liposome on leghorn cock comb," Chin. J. Laser Med. Sur. 14, 1–5 (2005).

[37] J. H. Ma, J. Q. Zhao, L. J. Jiang, "Photosensitization mechanism of active species by the complex of hypocrellin B with aluminum ion," Free Radical Res. 35, 607–617 (2001).

[38] J. H. Zhou, S. Q. Xia, J. R. Chen, X. S. Wang, B. W. Zhang, "The photodynamic property improvement of hypocrellin A by chelation with lanthanum ions," Chem. Commun. 1372–1373 (2003).

[39] J. H. Zhou, J. H. Liu, S. Q. Xia, X. S. Wang, B. W. Zhang, "Effect of chelation to lanthanum ions on the photodynamic properties of hypocrellin A," J. Phys. Chem. B 109, 19529–19535 (2005).

[40] Y. Sun, Y. J. Hou, Q. X. Zhou, W. H. Lei, J. R. Chen, X. S. Wang, B. W. Zhang, "Dinuclear Cu(II) hypocrellin B complexes with enhanced photonuclease activity," Inorg. Chem. 49, 10108–10116 (2010).

[41] Y. Sun, Y. J. Hou, Q. X. Zhou, J. R. Chen, B. W. Zhang, X. S. Wang, "A new Co(III)-hypocrellin B complex with enhanced photonuclease activity," J. Inorg. Biochem. 105, 978–984 (2011).

[42] Y. Sun, Y. Zheng,W. H. Lei, Q. X. Zhou, Y. J. Hou, B. W. Zhang, X. S. Wang, "Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity," Dalton T. 41, 651–657 (2012).

[43] Y. Z. Hu, J. Y. An, L. J. Jiang, L. C. Chiang, "Studies of the sulfonation of hypocrellin-A and the photodynamic actions of the product," J. Photochem. Photobiol. B-Biol. 17, 195–201 (1993).

[44] Y. Z. Hu, J. Y. An, L. C. Chiang, "Studies on the photoinduced sulfonation of hypocrellins," J. Photochem. Photobiol. A-Chem. 70, 301–308 (1993).

[45] Y. Y. He, J. Y. An, L. J. Jiang, "Synthesis and ESR investigation of hypocrellin glycoside," Tetrahedron Lett. 39, 5069–5072 (1998).

[46] Z. Z. Ou, J. R. Chen, X. S. Wang, B. W. Zhang, Y. Cao, "Synthesis of a water-soluble cyclodextrin modified hypocrellin and ESR study of its photodynamic therapy properties," New J. Chem. 26, 1130–1136 (2002).

[47] Y. Y. He, J. Y. An, L. J. Jiang, "Synthesis of a new water-soluble phototherapeutic sensitizer from hypocrellin B with enhanced red absorption," Dyes Pigm. 41, 93–100 (1999).

[48] S. J. Xu, X. X. Zhang, S. Chen, M. H. Zhang, T. Shen, Z. P. Wang, "Novel phototherapeutic agents: Investigation and progress of hypocrellin derivatives," Chin. Sci. Bull. 48, 1775–1785 (2003).

[49] J. Xie, J. H. Ma, J. Q. Zhao, "Prediction on amphiphilicity of hypocrellin derivatives," Sci. China Ser. B-Chem. 45, 251–256 (2002).

[50] M. Weng, M. H. Zhang, L. Ma, T. Shen, L. J. Jiang, "New long-wavelength perylenequinones. The reaction between hypocrellin B and mercapto compounds," Dyes Pigm. 35, 297–310 (1997).

[51] Y. J. Tang, H. Y. Liu, J. Y. An, R. Han, "Synthesis, characterization and photodynamic activity of amino-substituted hypocrellin derivatives," Photochem. Photobiol. 74, 201–205 (2001).

[52] S. J. Xu, S. Chen, M. H. Zhang, T. Shen, X. X. Zhang, Z. P. Wang, "Synthesis and characterization of three novel amphiphilic aminated hypocrellins as photodynamic therapeutic agents," Photochem. Photobiol. 78, 411–415 (2003).

[53] Z. H. Zeng, R. Qiao, J. H. Zhou, S. Q. Xia, Y. Zhang, Y. Y. Liu, J. R. Chen, X. S. Wang, B. W. Zhang, "Photodynamic properties of dipeptide-modified hypocrellin B derivatives: The role of tyrosine and tryptophan groups," J. Phys. Chem. B 111, 3742– 3749 (2007).

[54] H. Y. Lee, S. Chen, M. H. Zhang, T. Shen, "Studies on the synthesis of two hydrophilic hypocrellin derivatives with enhanced absorption in the red spectral region and on their photogeneration of O-2 (center dot-) and O-2((1)Delta(g))," J. Photochem. Photobiol. B-Biol. 71, 43–50 (2003).

[55] S. J. Xu, S. Chen, M. H. Zhang, T. Shen, Z. W. Liu, Y. P. Zhao, Y. D. Wu, "Cyclohexylamino-demethoxy- hypocrellin B and photodynamic therapy decreases human cancer in vitro," Anti-Cancer Drug Des. 16, 271–277 (2001).

[56] S. J. Xu, S. Chen, M. H. Zhang, T. Shen, "Synthesis, characterization and photodynamic activity of phenmethylamino-demethoxy-hypocrellin B," J. Photochem. Photobiol. B-Biol. 72, 61–67 (2003).

[57] S. J. Xu, S. Chen, M. H. Zhang, T. Shen, "Hypocrellin derivative with improvements of red absorption and active oxygen species generation," Bioorg. Med. Chem. Lett. 14, 1499–1501 (2004).

[58] Y. Zhang, L. M. Song, J. Xie, H. X. Qiu, Y. Gu, J. Q. Zhao, "Novel surfactant-like hypocrellin derivatives to achieve simultaneous drug delivery in blood plasma and cell uptake," Photochem. Photobiol. 86, 667–672 (2010).

[59] Y. W. Zhao, J. Xie, J. S. Ma, J. Q. Zhao, "A novel amphiphilic 2-taurine substituted hypocrellin B (THB) and its photodynamic activity," New J. Chem. 28, 484–489 (2004).

[60] M. Verhille, P. Couleaud, R. Vanderesse, D. Brault, M. Barberi-Heyob, C. Frochot, "Modulation of photosensitization processes for an improved targeted photodynamic therapy," Curr. Med. Chem. 17, 3925–3943 (2010).

[61] Y. Y. Liu, Q. X. Zhou, Z. H. Zeng, R. Qiao, X. S. Wang, B. W. Zhang, "Photodynamic properties of a bispyrrolecarboxamide-modified hypocrellin B: The role of a±nity and ascorbic acid," J. Phys. Chem. B 112, 9959–9965 (2008).

[62] S. Q. Xia, J. H. Zhou, J. R. Chen, X. S. Wang, B. W. Zhang, "A tyrosine-modified hypocrellin B with a±nity for and photodamaging ability towards calf thymus DNA," Chem. Commun. 2900–2901 (2003).

[63] L. Li, Y.W. Chen, J. Q. Shen, M. H. Zhang, T. Shen, "New long-wavelength perylenequinones: Synthesis and phototoxicity of hypocrellin B derivatives," Biochim. Biophys. Acta 1523, 6–12 (2000).

[64] X. Liu, J. Xie, L. Y. Zhang, H. X. Chen, Y. Gu, J. Q. Zhao, "Anovel hypocrellinB derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity," J. Photochem. Photobiol. B-Biol. 94, 171–178 (2009).

[65] Y. W. Zhao, J. Q. Zhao, "Preparation of a novel hypocrellin derivative and its photochemical, photophysical properties," Dyes Pigm. 63, 175–179 (2004).

[66] H. Deng, T. H. Li, J. Xie, N. Y. Huang, Y. Gu, J. Q. Zhao, "Synthesis and bio-evaluation of novel hypocrellin derivatives: Potential photosensitizers for photodynamic therapy of age-related macular degeneration," Dyes Pigm. 99, 930–939 (2013).

[67] T. A. Heming, S. K. Dave, D. M. Tuazon, A. K. Chopra, J. W. Peterson, A. Bidani, "Effects of extracellular pH on tumour necrosis factor-alpha production by resident alveolar macrophages," Clin. Sci. 101, 267–274 (2001).

[68] L. David, V. Dulong, D. Le Cerf, C. Chauzy, V. Norris, B. Delpech, M. Lamacz, J. P. Vannier, "Reticulated hyaluronan hydrogels: A model for examining cancer cell invasion in 3D," Matrix Biol. 23, 183–193 (2004).

[69] Y. Aoyagi, T. Oda, T. Kinoshita, C. Nakahashi, T. Hasebe, N. Ohkohchi, A. Ochiai, "Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer," Brit. J. Cancer 91, 1316–1326 (2004).

[70] M. Kongshaug, J. Moan, L. S. Cheng, G.M. Garbo, S. Kolboe, A. R. Morgan, C. Rimington, "Binding of drugs to human plasma-proteins, exemplified by Sn(Iv)-etiopurpurin dichloride delivered in cremophor and DMSO," International J. Biochem. 25, 739–760 (1993).

[71] K. Das, A. V. Smirnov, J. Wen, P. Miskovsky, J. W. Petrich, "Photophysics of hypericin and hypocrellin A in complex with subcellular components: Interactions with human serum albumin," Photochem. Photobiol. 69, 633–645 (1999).

[72] B. Z. Zhao, J. Xie, J. Q. Zhao, "Binding of hypocrellin B to human serum albumin and photo-induced interactions," Biochim. Biophys. Acta 1722, 124– 130 (2005).

[73] B. Z. Zhao, L. M. Song, X. Liu, J. Xie, J. Q. Zhao, "Spectroscopic studies of the interaction between hypocrellin B and human serum albumin," Bioorg. Med. Chem. 14, 2428–2432 (2006).

[74] J. Lesley, R. Hyman, N. English, J. B. Catterall, G. A. Turner, "CD44 in inflammation and metastasis," Glycoconjugate J. 14, 611–622 (1997).

[75] L. M. Song, B. Z. Zhao, J. Xie, J. Q. Zhao, "Interactions of hypocrellin B with hyaluronan and photo-induced interactions," Biochim. Biophys. Acta 1760, 333–339 (2006).

[76] L. M. Song, J. Xie, C. X. Zhang, C. Li, J. Q. Zhao, "Recognition of various biomolecules by the environment- sensitive spectral responses of hypocrellin B," Photochem. Photobiol. Sci. 6, 683–688 (2007).

[77] G. P. van-Balen, C. A. M. Martinet, G. Caron, G. Bouchard, M. Reist, P. A. Carrupt, R. Fruttero, A. Gasco, B. Testa, "Liposome/water lipophilicity: Methods, information content, and pharmaceutical applications," Med. Res. Rev. 24, 299–324 (2004).

[78] N. K. Srivastava, S. Pradhan, G. A. N. Gowda, R. Kumar, "In vitro, high-resolution H-1 and P-31 NMR based analysis of the lipid components in the tissue, serum, and CSF of the patients with primary brain tumors: One possible diagnostic view," NMR Biomed. 23, 113–122 (2010).

[79] J. L. Wikehooley, J. Haveman, H. S. Reinhold, "The relevance of tumor pH to the treatment of malignant disease," Radiother. Oncol. 2, 343–366 (1984).

[80] X. Y. Jin, Y. W. Zhao, J. Xie, J. Q. Zhao, "Fluorescence response of hypocrellin B to the environmental changes in a mimic biological membrane — liposome," Sci. China Ser. B-Chem. 47, 335–339 (2004).